CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6480-6488

  Porter, Kristen A ^a   Kelley, Lauren N ^a   Nekorchuk, Michael D ^a   Jones, James H ^a   Hahn, Amy B ^b   De Noronha, Carlos M C ^a   Harton, Jonathan A ^a   Duus, Karen M ^a  

^a Center for Immunology and Microbial Disease   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 160; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DM ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; SHORT HAIRPIN RNA;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; VIRUS ATTACHMENT; VIRUS RELEASE;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CLONE CELLS; GENE TARGETING; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMANS; JURKAT CELLS; LIGANDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRION; VIRUS ATTACHMENT;

EID: 78650667455     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000830     Document Type: Article

References (59)

1. Kamata, M., Y. Nagaoka, and I. S. Y. Chen. 2009. Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells. PLoS Pathog. 5: e1000342.
2. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
3. Gowda, S. D., B. S. Stein, N. Mohagheghpour, C. J. Benike, and E. G. Engleman. 1989. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J. Immunol. 142:773-780.
4. Holling, T. M., E. Schooten, and P. J. van den Elsen. 2004. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum. Immunol. 65:282-290.
5. Accolla, R. S., S. Mazza, A. de Lerma Barbaro, A. de Maria, and G. Tosi. 2002. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication. Eur. J. Immunol. 32:2783-2791.
6. Saifuddin, M., K. A. Roebuck, Ch. Chang, J. P. Ting, and G. T. Spear. 2000. Cutting edge: activation of HIV-1 transcription by the MHC class II transactivator. J. Immunol. 164:3941-3945.
7. Arthur, L. O., J. W. Bess, Jr., R. C. Sowder, II, R. E. Benveniste, D. L. Mann, J. C. Chermann, and L. E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938.
8. Cantin, R., J.-F. Fortin, G. Lamontagne, and M. Tremblay. 1997. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 90:1091-1100.
9. Esser, M. T., J. W. Bess, Jr., K. Suryanarayana, E. Chertova, D. Marti, M. Carrington, L. O. Arthur, and J. D. Lifson. 2001. Partial activation and induction of apoptosis in CD4 (+) and CD8 (+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J. Virol. 75:1152-1164.
10. Holm, G. H., and D. Gabuzda. 2005. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J. Virol. 79:6299-6311.
11. Mann, D. L., E. Read-Connole, L. O. Arthur, W. G. Robey, P. Wernet, E. M. Schneider, W. A. Blattner, and M. Popovic. 1988. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J. Immunol. 141:1131-1136.
12. Lawn, S. D., and S. T. Butera. 2000. Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection. J. Virol. 74:10256-10259.
13. Biancotto, A., S. J. Iglehart, C. Vanpouille, C. E. Condack, A. Lisco, E. Ruecker, I. Hirsch, L. B. Margolis, and J.-C. Grivel. 2008. HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood 111:699-704.
14. Bégaud, E., L. Chartier, V. Marechal, J. Ipero, J. Léal, P. Versmisse, G. Breton, A. Fontanet, C. Capoulade-Metay, H. Fleury, et al. 2006. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 3:35.
15. Card, C. M., P. J. McLaren, C. Wachihi, J. Kimani, F. A. Plummer, and K. R. Fowke. 2009. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4 (+) CD25 (+) FOXP3 (+) regulatory T cells. J. Infect. Dis. 199:1318-1322.
16. Koning, F. A., S. A. Otto, M. D. Hazenberg, L. Dekker, M. Prins, F. Miedema, and H. Schuitemaker. 2005. Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J. Immunol. 175:6117-6122.
17. Endres, M. J., P. R. Clapham, M. Marsh, M. Ahuja, J. D. Turner, A. McKnight, J. F. Thomas, B. Stoebenau-Haggarty, S. Choe, P. J. Vance, et al. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-756.
18. Duus, K. M., E. D. Miller, J. A. Smith, G. I. Kovalev, and L. Su. 2001. Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus. J. Virol. 75:3916-3924.
19. Chin, K. C., G. G. Li, and J. P. Ting. 1997. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501-2506.
20. Harton, J. A., and G. A. Bishop. 1993. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling. J. Immunol. 151:5282-5289.
21. Mörner, A., A. Björndal, J. Albert, V. N. Kewalramani, D. R. Littman, R. Inoue, R. Thorstensson, E. M. Fenyö, and E. Björling. 1999. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73:2343-2349.
22. Harton, J. A., D. E. Cressman, K. C. Chin, C. J. Der, and J. P. Ting. 1999. GTP binding by class II transactivator: role in nuclear import. Science 285:1402-1405.
23. Jamieson, B. D., and J. A. Zack. 1998. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J. Virol. 72:6520-6526.
24. Barrera, C. A., E. J. Beswick, J. C. Sierra, D. Bland, R. Espejo, R. Mifflin, P. Adegboyega, S. E. Crowe, P. B. Ernst, and V. E. Reyes. 2005. Polarized expression of CD74 by gastric epithelial cells. J. Histochem. Cytochem. 53:1481-1489.
25. Mattos-Graner, R. O., K. A. Porter, D. J. Smith, Y. Hosogi, and M. J. Duncan. 2006. Functional analysis of glucan binding protein B from Streptococcus mutans. J. Bacteriol. 188:3813-3825.
26. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45.
27. Schols, D., R. Pauwels, J. Desmyter, and E. de Clercq. 1992. Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis. Virology 189:374-376.
28. Porter, K. A., L. N. Kelley, A. George, J. A. Harton, and K. M. Duus. 2010. Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag. PLoS ONE 5: e11304.
29. Chen, P., W. Hübner, M. A. Spinelli, and B. K. Chen. 2007. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J. Virol. 81:12582-12595.
30. Hübner, W., P. Chen, A. del Portillo, Y. Liu, R. E. Gordon, and B. K. Chen. 2007. Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1. J. Virol. 81:12596-12607.
31. Riddell, S. R., and P. D. Greenberg. 1990. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods 128:189-201.
32. Vatakis, D. N., G. Bristol, T. A. Wilkinson, S. A. Chow, and J. A. Zack. 2007. Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. J. Virol. 81:3574-3582.
33. Yamada, S., and S. Ohnishi. 1986. Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes. Biochemistry 25:3703-3708.
34. Bukrinskaya, A., B. Brichacek, A. Mann, and M. Stevenson. 1998. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188:2113-2125.
35. Miyauchi, K., Y. Kim, O. Latinovic, V. Morozov, and G. B. Melikyan. 2009. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137:433-444.
36. Krawczyk, M., E. Leimgruber, Q. Seguín-Estévez, I. Dunand-Sauthier, E. Barras, and W. Reith. 2007. Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes. Nucleic Acids Res. 35:595-605.
37. Krawczyk, M., Q. Seguín-Estévez, E. Leimgruber, P. Sperisen, C. Schmid, P. Bucher, and W. Reith. 2008. Identification of CIITA regulated genetic module dedicated for antigen presentation. PLoS Genet. 4: e1000058.
38. El Fakhry, Y., M. Bouillon, C. Léveillé, A. Brunet, H. Khalil, J. Thibodeau, and W. Mourad. 2004. Delineation of the HLA-DR region and the residues involved in the association with the cytoskeleton. J. Biol. Chem. 279:18472-18480.
39. Kudo, H., T. Matsuoka, H. Mitsuya, Y. Nishimura, and S. Matsushita. 2002. Cross-linking HLA-DR molecules on Th1 cells induces anergy in association with increased level of cyclin-dependent kinase inhibitor p27 (Kip1). Immunol. Lett. 81:149-155.
40. Shin, J. S., M. Ebersold, M. Pypaert, L. Delamarre, A. Hartley, and I. Mellman. 2006. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444:115-118.
41. Spertini, F., T. Chatila, and R. S. Geha. 1992. Signals delivered via MHC class II molecules synergize with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells. J. Immunol. 149:65-70.
42. Zilber, M.-T., N. Setterblad, T. Vasselon, C. Doliger, D. Charron, N. Mooney, and C. Gelin. 2005. MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes. Blood 106:3074-3081.
43. Martin, B. K., K. C. Chin, J. C. Olsen, C. A. Skinner, A. Dey, K. Ozato, and J. P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6:591-600.
44. Gobin, S. J., A. Peijnenburg, M. van Eggermond, M. van Zutphen, R. van den Berg, and P. J. van den Elsen. 1998. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. Immunity 9:531-541.
45. Arndt, S. O., A. B. Vogt, S. Markovic-Plese, R. Martin, G. Moldenhauer, A. Wölpl, Y. Sun, D. Schadendorf, G. J. Hämmerling, and H. Kropshofer. 2000. Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 19:1241-1251.
46. Karacsonyi, C., T. Bedke, N. Hinrichsen, R. Schwinzer, and R. Lindner. 2005. MHC II molecules and invariant chain reside in membranes distinct from conventional lipid rafts. J. Leukoc. Biol. 78:1097-1105.
47. Xu, K. L., H. Li, X. Y. Pan, Z. Y. Li, Q. X. Lu, Y. Zhang, H. H. Zhu, B. Du, and L. Y. Zeng. 2007. Correlation of class II transactivator with HLA-DR antigen and its implications. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15:147-151.
48. Otten, L. A., V. Steimle, S. Bontron, and B. Mach. 1998. Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 28:473-478.
49. Mannhalter, J. W., H. M. Wolf, M. M. Eibl, Z. Küpcü, J. W. Mannhalter, and N. Barrett. 1990. In addition to CD4, HLA-DR might also be involved in the interaction of HIV-1 with the cell membrane. J. Immunol. 145:404-405.
50. Mannhalter, J. W., H. M. Wolf, I. Hauber, M. Miricka, H. Gadner, and M. M. Eibl. 1994. T cell differentiation and generation of the antigen-specific T cell repertoire in man: observations in MHC class II deficiency. Clin. Exp. Immunol. 97:392-395.
51. Reith, W., and B. Mach. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19:331-373.
52. Fu, X. T., and R. W. Karr. 1994. HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes. Hum. Immunol. 39:253-260.
53. Viken, H. D., A. B. Thoresen, I. Knutsen, E. Thorsby, and T. Hansen. 1995. Serologic subtyping of HLA-DR8 by means of the cytotoxic human monoclonal antibody 5643. Hum. Immunol. 43:200-206.
54. Decker, J. M., K. P. Zammit, J. L. Easlick, M. L. Santiago, D. Bonenberger, B. H. Hahn, O. Kutsch, and F. Bibollet-Ruche. 2009. Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes. Virology 394:109-118.
55. Maenetje, P., C. Riou, J. P. Casazza, D. Ambrozak, B. Hill, G. Gray, R. A. Koup, G. de Bruyn, and C. M. Gray. 2010. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection. J. Immunol. 184:4926-4935.
56. Mehandru, S., K. Tenner-Racz, P. Racz, and M. Markowitz. 2005. The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection. J. Allergy Clin. Immunol. 116:419-422.
57. Huisman, W., B. E. Martina, G. F. Rimmelzwaan, R. A. Gruters, and A. D. Osterhaus. 2009. Vaccine-induced enhancement of viral infections. Vaccine 27:505-512.
58. Hutnick, N. A., D. G. Carnathan, S. A. Dubey, K. S. Cox, L. Kierstead, S. J. Ratcliffe, M. N. Robertson, D. R. Casimiro, H. C. Ertl, and M. R. Betts. 2009. Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. Nat. Med. 15:876-878.
59. Douek, D. C., J. M. Brenchley, M. R. Betts, D. R. Ambrozak, B. J. Hill, Y. Okamoto, J. P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, et al. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98.